Hoitt Jason 4
4 · Provention Bio, Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Hoitt Jason
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-18+145,000→ 145,000 totalExercise: $4.39Exp: 2032-01-18→ Common Stock, par value $0.0001 (145,000 underlying)
Footnotes (2)
- [F1]The options will vest and become exercisable as to 25% on the one-year anniversary of the grant date (January 18, 2023) and the remaining 75% will vest and become exercisable monthly over 36 months such that the options are fully vested and exercisable on the four-year anniversary of the grant date (January 18, 2026).
- [F2]The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.